Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.
about
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signalingCoxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markersOrgan-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.The PI3K/Akt/mTOR pathway is involved in CVB3-induced autophagy of HeLa cells.Sporadic isolation of sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination.Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice.Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulationCyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice.Update on coxsackievirus B3 myocarditis.Coagulation, protease-activated receptors, and viral myocarditis.Polymorphisms in genes encoding nonsarcomeric proteins and their role in the pathogenesis of dilated cardiomyopathy.Development and use of an Arctic charr cell line to study antiviral responses at extremely low temperatures.Current insights into LMNA cardiomyopathies: Existing models and missing LINCsThe Prevalence and Findings of Subclinical Influenza-associated Cardiac Abnormalities among Japanese Patients.Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice.
P2860
Q27316099-1D5C075F-AE76-4DF0-B7CF-D6139BA6B882Q27329437-B87ACA31-74BD-40D5-BBF8-4724E768F0A6Q30393778-BF6791ED-62A6-4FCC-BC0D-7F14CE084E32Q33783958-A202A855-2F90-40C8-ACA8-9920A08B0448Q34106920-6F2A7480-F341-4A39-BAED-7DC24AE732A1Q34921442-6CDD9F31-82EE-4911-A7A2-99C98E82417AQ35391084-A7C0E07C-37CE-4347-AF2D-D087B7881BF0Q35777110-F3DA69D2-40E6-4F68-A3C8-D9C162064EE7Q35954527-9937BB7F-88A5-4E3A-ACCD-63ADF6530E03Q37619823-A10D92AF-0ECA-4A2B-8E93-78E277377C9CQ38063141-865E6CAA-CF67-4724-AC6B-6B04E713EAD2Q38713592-7E3BCF9E-86D1-4BBE-9A03-38445EB5E754Q39104972-B78217E0-C295-4575-AF92-F7CC60EBF243Q52680747-5E98FCA6-9371-4683-9080-4ABD68DB93D9Q55118783-F95FF8A0-A688-4CC8-B3EC-62834BC76FE9
P2860
Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Viral myocarditis: potential d ...... ocyte against virus infection.
@en
Viral myocarditis: potential d ...... ocyte against virus infection.
@nl
type
label
Viral myocarditis: potential d ...... ocyte against virus infection.
@en
Viral myocarditis: potential d ...... ocyte against virus infection.
@nl
prefLabel
Viral myocarditis: potential d ...... ocyte against virus infection.
@en
Viral myocarditis: potential d ...... ocyte against virus infection.
@nl
P2860
P356
P1433
P1476
Viral myocarditis: potential d ...... ocyte against virus infection.
@en
P2093
Toshitaka Yajima
P2860
P304
P356
10.2217/FMB.11.40
P577
2011-05-01T00:00:00Z